Myelogenous Leukemia
📧 Sign up to get email alerts when something new happens for Myelogenous Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 trial is evaluating the safety and efficacy of pioglitazone in combination with imatinib mesylate for chronic myelogenous leukemia…
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML [Phase 3]
Phase 3 study of BMS-354825 (nilotinib) in chronic-phase chronic myelogenous leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004) [Phase 1, Phase 2]
This clinical trial update reports on a phase 1/2 study evaluating the combination of imatinib and hydroxyurea for chronic myelogenous leuke…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Investigation of Clofarabine in Acute Leukemias [Phase 2]
Phase 2 trial of clofarabine in acute myeloid leukemia, acute lymphoblastic leukemia, and chronic myelogenous leukemia has completed enrollm…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
This clinical trial update reports results from a Phase 2 study evaluating chemotherapy followed by bone marrow transplantation in patients …
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants [Phase 2]
Phase 2 clinical trial update on methods to enhance safety and effectiveness of stem cell transplants.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases [Phase 1]
Phase 1 trial update on belinostat plus azacitidine in adults with advanced hematologic cancers. The study has completed enrollment and eval…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec [Phase 2]
Open-label Phase II study of sorafenib (BAY 43-9006) in chronic myelogenous leukemia patients resistant to imatinib (Gleevec) has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Investigation of the Cylex® ImmuKnow® Assay
A completed clinical trial investigating the Cylex ImmuKnow immune function assay across several hematologic diseases.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer [NA]
This clinical-trial update reports completion and results posting for palifermin used to prevent chronic graft-versus-host disease in patien…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation [Phase 1]
A Phase 1 trial evaluating PR1-specific cytotoxic T-lymphocyte infusion for recurrent chronic myelogenous leukemia after allogeneic hematopo…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Intraosseous Infusion of Unrelated Cord Blood Grafts [NA]
Clinical trial evaluating intraosseous infusion of unrelated cord blood grafts was terminated; sponsor was Emory University, and it studied …
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors [NA]
A completed clinical trial evaluating how imatinib affects bone metabolism in patients with chronic myelogenous leukemia or gastrointestinal…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [Phase 1]
Phase 1 trial evaluating Tanespimycin in combination with Cytarabine in adults with relapsed or refractory acute myeloid leukemia, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial of SJG-136 in relapsed or refractory hematologic cancers (acute myeloid leukemia subtypes, myelodysplastic syndromes, blast-ph…
-
CLINICAL_TRIALS research · 2013-07-17Clinical Trial Update: Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission [Phase 4]
Phase 4 clinical trial assessing the growth hormone–IGF-1 axis in children with chronic myelogenous leukemia in remission.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia [Phase 1, Phase 2]
This clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating STI571 (imatinib) in combination with chemotherapy f…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 study evaluated the combination of Oblimersen with Imatinib Mesylate in patients with chronic myelogenous leukemia, including BCR-…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 clinical trial of flavopiridol (alvocidib) in relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chro…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy with peripheral stem cell transplantation for chronic myelogenous leukemia and acut…